Literature DB >> 22367022

Metadherin regulates radioresistance in cervical cancer cells.

Ying Zhao1, Meena S Moran, Qifeng Yang, Qiao Liu, Cunzhong Yuan, Shuhui Hong, Beihua Kong.   

Abstract

Metadherin (MTDH) promotes cancer metastasis, chemoresistance, invasion and angiogenesis. Upregulation of MTDH is correlated with both progression and poor clinical outcome of many types of cancers; however, there is currently no information regarding the role of MTDH in radiation sensitivity. Here, we investigated the effects of MTDH on the radiosensitivity of cervical cancer cells using the SiHa cell line. We discovered that cervical cancer cells in which MTDH was knocked down had significantly increased radiosensitivity as measured by a clonogenic assay. MTDH knockdown cells also had increased apoptosis and a decreased proportion of cells arrested in the G2 phase after radiation treatment. MTDH knockdown also weakened the repair of DNA double-strand breaks (DSBs) induced by radiation. These results indicate that MTDH affects the radiosensitivity of cervical cancer cells and that MTDH may be a novel target to improve cervical cancer radiation response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22367022     DOI: 10.3892/or.2012.1692

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  15 in total

Review 1.  Drug resistance mediated by AEG-1/MTDH/LYRIC.

Authors:  Xiangbing Meng; Kristina W Thiel; Kimberly K Leslie
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

2.  Metadherin in prostate, bladder, and kidney cancer: A systematic review.

Authors:  Zhao Wang; Yong-Bao Wei; Yun-Liang Gao; Bin Yan; Jin-Rui Yang; Qiong Guo
Journal:  Mol Clin Oncol       Date:  2014-08-18

3.  Prognostic impact of Metadherin-SND1 interaction in colon cancer.

Authors:  Nan Wang; Xilin Du; Li Zang; Nuan Song; Tao Yang; Rui Dong; Tao Wu; Xianli He; Jianguo Lu
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

4.  Metadherin confers chemoresistance of cervical cancer cells by inducing autophagy and activating ERK/NF-κB pathway.

Authors:  Jingwei Zhang; Yunyan Zhang; Shuang Liu; Qingmeng Zhang; Yan Wang; Liping Tong; Xiaohang Chen; Yuting Ji; Qinglong Shang; Baozhan Xu; Ming Chu; Lanlan Wei
Journal:  Tumour Biol       Date:  2013-04-18

5.  The relevance of molecular biomarkers in cervical cancer patients treated with radiotherapy.

Authors:  Sarah Kilic; Bernadette Cracchiolo; Molly Gabel; Bruce Haffty; Omar Mahmoud
Journal:  Ann Transl Med       Date:  2015-10

6.  Prognostic significance of astrocyte elevated gene-1 in human astrocytomas.

Authors:  Zhangxiu He; Meihui He; Chao Wang; Baozhan Xu; Liping Tong; Junming He; Bowen Sun; Lanlan Wei; Ming Chu
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

7.  The MTDH (-470G>A) polymorphism is associated with ovarian cancer susceptibility.

Authors:  Cunzhong Yuan; Xiao Li; Shi Yan; Qifeng Yang; Xiaoyan Liu; Beihua Kong
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

8.  Progress of cancer research on astrocyte elevated gene-1/Metadherin (Review).

Authors:  Yong Huang; LE-Ping Li
Journal:  Oncol Lett       Date:  2014-06-05       Impact factor: 2.967

9.  AEG-1 expression is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy: a study in a Swedish clinical trial.

Authors:  S Gnosa; H Zhang; V P Brodin; J Carstensen; G Adell; X-F Sun
Journal:  Br J Cancer       Date:  2014-05-29       Impact factor: 7.640

Review 10.  Astrocyte elevated gene-1 (AEG-1): A key driver of hepatocellular carcinoma (HCC).

Authors:  Indranil Banerjee; Paul B Fisher; Devanand Sarkar
Journal:  Adv Cancer Res       Date:  2021-06-16       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.